申请人:Singh Rajinder
公开号:US20150266828A1
公开(公告)日:2015-09-24
The present invention provides 2,4-pyrimidinediamine compounds that inhibit the IgE and/or IgG receptor signaling cascades that lead to the release of chemical mediators, intermediates and methods of synthesizing the compounds and methods of using the compounds in a variety of contexts, including in the treatment and prevention of diseases characterized by, caused by or associated with the release of chemical mediators via degranulation and other processes effected by activation of the IgE and/or IgG receptor signaling cascades.
本发明提供了抑制IgE和/或IgG受体信号级联反应的2,4-嘧啶二胺化合物,该级联反应导致化学介质的释放,以及合成这些化合物的中介体和方法,以及在多种情况下使用这些化合物的方法,包括在治疗和预防由脱粒和其他由IgE和/或IgG受体信号级联反应激活引起的化学介质释放所表征、引起或相关的疾病。